Mass spectrometry assay method for detection and quantitation of organic acid metabolites

    公开(公告)号:US11061005B2

    公开(公告)日:2021-07-13

    申请号:US16604357

    申请日:2018-04-16

    申请人: Metabolon, Inc.

    摘要: A method for determining in a sample, by mass spectrometry, the presence, absence, or amount of one or more analytes is described herein. The run time is less than six minutes. The method includes subjecting the sample to an ionization source under conditions suitable to produce one or more ions detectable by mass spectrometry from each of the one or more analytes, wherein the one or more analytes are derivatized prior to ionization; measuring, in a single injection, by mass spectrometry, the amount of the one or more ions from each of the one or more analytes; and using the measured amount of the one or more ions to determine the amount of each of the one or more analytes in the sample.

    MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF LIVER FUNCTION METABOLITES

    公开(公告)号:US20210148924A1

    公开(公告)日:2021-05-20

    申请号:US17043165

    申请日:2019-04-01

    申请人: METABOLON, INC.

    摘要: A method for determining in a sample, by mass spectrometry, the amount of one or more analytes selected from the group consisting of 12,13-DiHOME, 3-hydroxybutyrate (BHBA), 3-hydroxyoctanoate, 3-methylglutarylcarnitine, 3-ureidopropionate, 7-alpha-hydroxy-4-cholesten-3-one (7-Hoca), citrate, fucose, fumarate, gamma-tocopherol, glutamate, glutarate, glycerol, glycochenodeoxycholate, glycocholate, hypoxanthine, maleate, malonate, mannose, orotate, 2,3-pyrdinedicarboxylate, ribose, serine, taurine, taurochenodeoxycholate, taurocholate, palmitoleate, linolenate, xanthine, xylitol, and combinations thereof is described. The method comprises subjecting the sample to an ionization source under conditions suitable to produce one or more ions detectable by mass spectrometry from each of the one or more analytes; measuring, by mass spectrometry, the amount of the one or more ions from each of the one or more analytes; and using the measured amount to determine the amount of each of the one or more analytes in the sample.

    COMPOUNDS, REAGENTS, AND USES THEREOF
    43.
    发明申请

    公开(公告)号:US20200231541A1

    公开(公告)日:2020-07-23

    申请号:US16650429

    申请日:2018-09-27

    申请人: Metabolon, Inc.

    发明人: Qibo Zhang

    摘要: The present invention provides a compound of formula (I), formula (II), formula (III), (IV) or a salt thereof, compositions and methods of making the compound, methods and reagents for measuring the compound, and kits using the same. The use of a compound of formula (I), formula (II), formula (III), or formula (IV) for assessing or monitoring kidney function in a subject, determining predisposition to developing reduced kidney function, classifying a subject according to level of kidney function, and diagnosing or monitoring chronic kidney disease is also described.

    BIOMARKERS OF DE NOVO LIPOGENESIS AND METHODS USING THE SAME
    47.
    发明申请
    BIOMARKERS OF DE NOVO LIPOGENESIS AND METHODS USING THE SAME 审中-公开
    DE NOVO生物标记生物标记物及其使用方法

    公开(公告)号:US20160356798A1

    公开(公告)日:2016-12-08

    申请号:US15104560

    申请日:2014-12-18

    申请人: METABOLON, INC.

    发明人: Steven M. WATKINS

    IPC分类号: G01N33/92

    摘要: Biomarkers relating to de novo lipogenesis are provided, as well as methods for using such biomarkers in an Index to assess DNL. In addition, methods for diagnosing, determining predisposition to, and monitoring progression/regression of diseases related to DNL are provided. Also provided are methods of monitoring the efficacy of treatments for diseases related to DNL as well as other methods based on biomarkers of DNL.

    摘要翻译: 提供了与新生脂肪生成相关的生物标志物,以及在索引中使用这些生物标志物评估DNL的方法。 此外,还提供了诊断,确定与DNL相关疾病的倾向和监测进展/退化的方法。 还提供了监测与DNL相关疾病的治疗功效以及基于DNL生物标志物的其它方法的方法。

    BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME
    48.
    发明申请
    BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME 审中-公开
    与KIDNEY功能相关的生物标记和使用该功能的方法

    公开(公告)号:US20160116486A1

    公开(公告)日:2016-04-28

    申请号:US14889930

    申请日:2014-05-13

    申请人: METABOLON, INC.

    IPC分类号: G01N33/68 G01N33/70 G01N33/64

    摘要: Biomarkers of kidney function and methods for using said biomarkers for assessing kidney function, monitoring kidney function, diagnosing acute kidney injury, and diagnosing chronic kidney disease are provided. Also provided are suites of small molecule entities as biomarkers for chronic kidney disease.

    摘要翻译: 提供了肾脏功能的生物标志物和使用所述生物标志物评估肾功能,监测肾功能,诊断急性肾损伤和诊断慢性肾脏疾病的方法。 还提供了小分子实体的套件作为慢性肾脏疾病的生物标志物。

    METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR METABOLOMICS ANALYSIS
    50.
    发明申请
    METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR METABOLOMICS ANALYSIS 审中-公开
    方法,装置和计算机程序产品的代谢分析

    公开(公告)号:US20160019335A1

    公开(公告)日:2016-01-21

    申请号:US14856184

    申请日:2015-09-16

    申请人: METABOLON, INC.

    IPC分类号: G06F19/12 G06F19/24 G06F19/26

    CPC分类号: G16B45/00 G16B5/00 G16B40/00

    摘要: A method is provided for analyzing metabolite data in a sample, comprising analyzing a sample to determine a first number of metabolites, and amount of each metabolite, included in the sample, and a second number of the first number of metabolites that are regulated. Biochemical pathways are determined, each having a third number of the first number of metabolites that are included in the sample and in the determined biochemical pathway. For each of the determined biochemical pathways having the third number of metabolites, a fourth number of the second number of metabolites that are included in the sample and in the determined biochemical pathway that are regulated metabolites is determined. Each of the third number of metabolites within one of the determined biochemical pathways is displayed and distinguished by the amount of each corresponding metabolite included in the sample. An associated apparatus and computer program product are also provided.

    摘要翻译: 提供了一种用于分析样品中的代谢物数据的方法,包括分析样品以确定第一数量的代谢物,以及包含在样品中的每种代谢物的量和被调节的第二数量的代谢物。 确定生物化学途径,每个具有第三数量的第一数量的代谢物,其包括在样品中和在确定的生物化学途径中。 对于具有第三代谢物数量的确定的生物化学途径的每一个,测定包含在样品中的第二数量的代谢物和被调节的代谢物的确定的生物化学途径。 在所确定的生物化学途径之一内的第三代代谢物中的每一种被显示并且通过样品中包含的每个相应代谢物的量来区分。 还提供了相关联的设备和计算机程序产品。